Price Alert

AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

205.46

0.78 (0.38%)

At close: Aug 15, 2025, 12:14 PM

AbbVie Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	58.33B	57.37B	56.33B	55.53B	55B	54.4B	54.32B	55.14B	56.02B	56.74B	58.05B	57.82B	57.35B	56.73B	56.2B	55.17B	53.73B	50.2B
Cost of Revenue	15.01B	16.81B	16.9B	18.21B	20.48B	20.52B	20.41B	18.88B	17.42B	17.35B	17.41B	17.56B	16.93B	17.29B	17.45B	17.81B	18.47B	17.66B
Gross Profit	43.31B	40.55B	39.43B	37.32B	34.52B	33.88B	33.9B	36.26B	38.6B	39.39B	40.64B	40.26B	40.42B	39.44B	38.75B	37.36B	35.26B	32.54B
Operating Income	11.94B	10.07B	9.14B	13.82B	12.27B	12.79B	12.76B	15.06B	17.39B	16.17B	18.12B	17.69B	17.39B	18.54B	17.92B	16.6B	15.55B	11.86B
Interest Income	294M	514M	648M	742M	770M	648M	540M	444M	350M	276M	186M	105M	53M	38M	39M	41M	40M	49M
Pretax Income	3.03B	3.62B	3.72B	7.2B	7.07B	7.53B	6.25B	8B	10.45B	9.02B	13.48B	14.78B	14.07B	14.05B	12.99B	7.21B	6.02B	4.17B
Net Income	3.77B	4.2B	4.28B	5.12B	5.34B	5.99B	4.86B	6.51B	8.69B	7.58B	11.84B	13.41B	12.64B	12.48B	11.54B	7.53B	6.66B	5.16B
Selling & General & Admin	13.6B	13.75B	13.78B	14.09B	13.26B	13.15B	12.87B	13.1B	13.03B	15.17B	15.26B	15.1B	14.88B	12.54B	12.26B	12.23B	11.99B	12.45B
Research & Development	13.07B	12.92B	12.79B	8.23B	7.82B	7.6B	7.96B	7.78B	7.67B	7.82B	7.17B	7.37B	7.82B	7.84B	8.05B	8B	7.65B	8.18B
Other Expenses	4.71B	3.81B	3.73B	1.18B	1.17B	341M	317M	316M	479M	196M	56M	57M	328M	500M	500M	500M	45M	45M
Operating Expenses	31.38B	30.48B	30.29B	23.5B	22.24B	21.09B	21.15B	21.19B	21.18B	23.18B	22.48B	22.53B	23.02B	20.9B	20.83B	20.76B	19.71B	20.67B
Interest Expense	2.8B	2.85B	2.81B	2.67B	2.5B	2.33B	2.22B	2.23B	2.23B	2.23B	2.23B	2.24B	2.28B	2.34B	2.42B	2.47B	2.51B	2.52B
Selling & Marketing Expenses	2.1B	2.1B	2.1B	n/a	n/a	n/a	n/a	2B	2B	2B	2B	2.1B	2.1B	2.1B	2.1B	n/a	n/a	n/a
Cost & Expenses	46.39B	47.3B	47.2B	41.71B	42.73B	41.62B	41.56B	40.07B	38.64B	40.57B	39.94B	40.13B	39.96B	38.19B	38.27B	38.57B	38.18B	38.33B
Income Tax Expense	-741M	-581M	-570M	2.06B	1.72B	1.53B	1.38B	1.48B	1.76B	1.43B	1.63B	1.36B	1.43B	1.56B	1.44B	-331M	-652M	-1B
Shares Outstanding (Basic)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B
Shares Outstanding (Diluted)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.77B
EPS (Basic)	2.11	2.36	2.41	2.89	3.01	3.37	2.73	3.67	4.90	4.28	6.69	7.58	7.13	7.03	6.49	4.21	3.73	2.86
EPS (Diluted)	2.11	2.36	2.41	2.89	3.01	3.37	2.73	3.66	4.88	4.25	6.65	7.52	7.08	6.99	6.45	4.20	3.71	2.84
EBITDA	12.05B	14.82B	14.91B	18.23B	18.09B	18.51B	17.17B	19.01B	21.43B	19.8B	24.17B	25.32B	24.56B	24.75B	23.93B	18.29B	17.3B	14.82B
EBIT	5.83B	6.47B	6.52B	9.87B	9.57B	9.86B	8.47B	10.23B	12.68B	11.26B	15.71B	17.03B	16.35B	16.39B	15.41B	9.68B	8.53B	6.69B
Depreciation & Amortization	6.22B	8.35B	8.39B	8.36B	8.52B	8.64B	8.7B	8.78B	8.75B	8.54B	8.47B	8.29B	8.21B	8.36B	8.52B	8.61B	8.77B	8.13B